drug

Standard treatment

Standard Treatment
as of 2026-07-01
Add to landscapeMonitor thisCompare thisAsk about this
at a glance
BEHAVIORAL
Pre-approval / investigational in the US
Developed by Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)
2 trials in the graph
Synthesized from structured facts only — each point cited above.

Mechanism & identity

Modality
BEHAVIORAL

Indications

Trials

2
Effects of Neurocognitive and Social Cognitive Remediation in Patients at Ultra-High Risk of Psychosis
NCT02098408—Completed
Cognitive Behavioural Therapy- Social Functioning In Adolescence With Recent Onset Schizophrenia
NCT03217955—Completed

KOLs & investigators

3
Louise Birkedal GlenthøjKOL score 9
Merete Nordentoft, MD, PhD, MPHKOL score 8
Lieuwe de Haan, Ph.D.

Facts & assertions

0 sourced
No assertions recorded for this entity.
relationships
The graph out of here
developer
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)
company
trial
Effects of Neurocognitive and Social Cognitive Remediation in Patients at Ultra-High Risk of Psychosis
NA
trial
Cognitive Behavioural Therapy- Social Functioning In Adolescence With Recent Onset Schizophrenia
NA
trial
indication
Patients at Ultra-high Risk of Psychosis
indication
Psychotic Disorders
indication
Psychotic Disorders
indication
KOL
Louise Birkedal Glenthøj
KOL score 9
person
Merete Nordentoft, MD, PhD, MPH
KOL score 8
person
Lieuwe de Haan, Ph.D.
KOL score —
person